{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:44:37Z","timestamp":1770741877968,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["HE 8803\/1\u20131"],"award-info":[{"award-number":["HE 8803\/1\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["418081722"],"award-info":[{"award-number":["418081722"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["433158657"],"award-info":[{"award-number":["433158657"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adult polyglucosan body disease (APBD) is a rare but probably underdiagnosed autosomal recessive neurodegenerative disorder due to pathogenic variants in <jats:italic>GBE1<\/jats:italic>. The phenotype is characterized by neurogenic bladder dysfunction, spastic paraplegia, and axonal neuropathy. Additionally, cognitive symptoms and dementia have been reported in APBD but have not been studied systematically. Using exome sequencing, we identified two previously unreported bi-allelic missense <jats:italic>GBE1<\/jats:italic> variants in a patient with severe memory impairment along with the typical non-cognitive symptoms. We were able to confirm a reduction of GBE1 activity in blood lymphocytes. To characterize the neuropsychological profile of patients suffering from APBD, we conducted a systematic review of cognitive impairment in this rare disease. Analysis of 24 cases and case series (in total 58 patients) showed that executive deficits and memory impairment are the most common cognitive symptoms in APBD.<\/jats:p>","DOI":"10.1007\/s00415-022-10960-z","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T18:02:26Z","timestamp":1641664946000},"page":"2854-2861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of cognitive impairment in adult polyglucosan body disease"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9330-6620","authenticated-orcid":false,"given":"Paul Theo","family":"Zebhauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Cordts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Haslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan Orhan","family":"Akman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias B.","family":"Haack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"issue":"3","key":"10960_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jimd.12325","volume":"44","author":"PVS Souza","year":"2021","unstructured":"Souza PVS et al (2021) GBE1-related disorders: Adult polyglucosan body disease and its neuromuscular phenotypes. J Inherit Metab Dis 44(3):534\u2013543. https:\/\/doi.org\/10.1002\/jimd.12325","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10960_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.23598","volume":"72","author":"F Mochel","year":"2012","unstructured":"Mochel F et al (2012) Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings. Ann Neurol 72(3):433\u2013441. https:\/\/doi.org\/10.1002\/ana.23598","journal-title":"Ann Neurol"},{"issue":"10","key":"10960_CR3","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s00415-015-7859-4","volume":"262","author":"MA Hellmann","year":"2015","unstructured":"Hellmann MA et al (2015) Frequent misdiagnosis of adult polyglucosan body disease. J Neurol 262(10):2346\u20132351. https:\/\/doi.org\/10.1007\/s00415-015-7859-4","journal-title":"J Neurol"},{"key":"10960_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/BF00867422","author":"P Boulan-Predseil","year":"1995","unstructured":"Boulan-Predseil P, Vital A, Brochet B, Darriet D, Henry P, Vital C (1995) Dementia of frontal lobe type due to adult polyglucosan body disease. J Neurol. https:\/\/doi.org\/10.1007\/BF00867422","journal-title":"J Neurol"},{"issue":"1","key":"10960_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/13554794.2011.654217","volume":"19","author":"JG Farmer","year":"2013","unstructured":"Farmer JG, Crain BJ, Harris BT, Turner RS (2013) Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions. Neurocase 19(1):67\u201375","journal-title":"Neurocase"},{"issue":"2","key":"10960_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mus.10520","volume":"29","author":"CJ Klein","year":"2004","unstructured":"Klein CJ et al (2004) Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome. Muscle Nerve 29(2):323\u2013328. https:\/\/doi.org\/10.1002\/mus.10520","journal-title":"Muscle Nerve"},{"issue":"3","key":"10960_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/acn3.394","volume":"4","author":"K Lee","year":"2017","unstructured":"Lee K, Ernst T, L\u00f8haugen G, Zhang X, Chang L (2017) Neural correlates of adaptive working memory training in a glycogen storage disease type-IV patient. Ann Clin Transl Neurol 4(3):217\u2013222. https:\/\/doi.org\/10.1002\/acn3.394","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10960_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.410300505","volume":"30","author":"A Lossos","year":"1991","unstructured":"Lossos A et al (1991) Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. Ann Neurol 30(5):655\u2013662. https:\/\/doi.org\/10.1002\/ana.410300505","journal-title":"Ann Neurol"},{"key":"10960_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.5.788","author":"NP Robertson","year":"1998","unstructured":"Robertson NP, Wharton S, Anderson J, Scolding NJ (1998) Adult polyglucosan body disease associated with an extrapyramidal syndrome. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp.65.5.788","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10960_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2006.03.001","author":"G Savage","year":"2007","unstructured":"Savage G, Ray F, Halmagyi M, Blazely A, Harper C (2007) Stable neuropsychological deficits in adult polyglucosan body disease. J Clin Neurosci. https:\/\/doi.org\/10.1016\/j.jocn.2006.03.001","journal-title":"J Clin Neurosci"},{"key":"10960_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20384","author":"EE Ubogu","year":"2005","unstructured":"Ubogu EE et al (2005) Adult polyglucosan body disease: a case report of a manifesting heterozygote. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.20384","journal-title":"Muscle Nerve"},{"key":"10960_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"10960_CR13","volume-title":"Testbatterie zur Aufmerksamkeitspr\u00fcfung (TAP)","author":"P Zimmermann","year":"1993","unstructured":"Zimmermann P, Fimm B (1993) Testbatterie zur Aufmerksamkeitspr\u00fcfung (TAP). Psytest, Freiburg"},{"key":"10960_CR14","unstructured":"Thalmann B et al. (1997) CERAD - Consortium to Establish a Registry for Alzheimer\u2019s Disease Assessment Battery - deutsche Fassung (CERAD-NP-Testbatterie; Consortium to Establish a Registry for Alzheimer\u2019s Disease-Neuropsychological Assessment Battery (CERAD-NAB)). (PSYNDEX Tests Review)"},{"key":"10960_CR15","unstructured":"H\u00e4rting C, Markowitsch HJ, Neufeld H, Calabrese P, Deisinger K, Kessler J (2000) WMS-R - Wechsler Ged\u00e4chtnistest - revidierte Fassung"},{"issue":"3","key":"10960_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"J Psychiatr Res"},{"key":"10960_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-108064","author":"RJ Falb","year":"2021","unstructured":"Falb RJ et al (2021) Bi-allelic loss-of-function variants in KIF21A cause severe fetal akinesia with arthrogryposis multiplex. J Med Genet. https:\/\/doi.org\/10.1136\/jmedgenet-2021-108064","journal-title":"J Med Genet"},{"issue":"5","key":"10960_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"10960_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s002340000425","author":"M Berkhoff","year":"2001","unstructured":"Berkhoff M, Weis J, Schroth G, Sturzenegger M (2001) Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology. https:\/\/doi.org\/10.1007\/s002340000425","journal-title":"Neuroradiology"},{"key":"10960_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12144","author":"EN Bit-Ivan","year":"2014","unstructured":"Bit-Ivan EN et al (2014) Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12144","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10960_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330114","author":"C Bruno","year":"1993","unstructured":"Bruno C et al (1993) Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.410330114","journal-title":"Ann Neurol"},{"issue":"3","key":"10960_CR22","first-page":"4092","volume":"9","author":"M Franco-Palacios","year":"2016","unstructured":"Franco-Palacios M et al (2016) Adult polyglucosan body disease with reduced glycogen branching enzyme activity and heterozygous GBE1 mutation mimicking a low-grade glioma. Int J Clin Exp Pathol 9(3):4092\u20134100","journal-title":"Int J Clin Exp Pathol"},{"key":"10960_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-198807000-00007","author":"F Gray","year":"1988","unstructured":"Gray F, Gherardi R, Marshall A, Janota I, Poirier J (1988) Adult polyglucosan body disease (APBD). J Neuropathol Exp Neurol. https:\/\/doi.org\/10.1097\/00005072-198807000-00007","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10960_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/NXG.0000000000000138","volume":"3","author":"Y Harigaya","year":"2017","unstructured":"Harigaya Y et al (2017) Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease. Neurol Genet 3(2):138. https:\/\/doi.org\/10.1212\/NXG.0000000000000138","journal-title":"Neurol Genet"},{"key":"10960_CR25","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2007.48.4.701","author":"S-Y Lee","year":"2007","unstructured":"Lee S-Y, Park J-H, Kim SH, Kim T-S, Kim W-J, Choi Y-C (2007) A case of adult polyglucosan body disease. Yonsei Med J. https:\/\/doi.org\/10.3349\/ymj.2007.48.4.701","journal-title":"Yonsei Med J"},{"key":"10960_CR26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003945","author":"AS L\u00f3pez Chiriboga","year":"2017","unstructured":"L\u00f3pez Chiriboga AS (2017) Teaching neuroimages: prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000003945","journal-title":"Neurology"},{"key":"10960_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440604","author":"A Lossos","year":"1998","unstructured":"Lossos A et al (1998) Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.410440604","journal-title":"Ann Neurol"},{"key":"10960_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20916","author":"R Massa","year":"2008","unstructured":"Massa R, Bruno C, Martorana A, de Stefano N, van Diggelen OP, Federico A (2008) Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.20916","journal-title":"Muscle Nerve"},{"key":"10960_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540130124021","author":"Z Rifai","year":"1994","unstructured":"Rifai Z et al (1994) Dementia of adult polyglucosan body disease. Evidence of cortical and subcortical dysfunction. Arch Neurol. https:\/\/doi.org\/10.1001\/archneur.1994.00540130124021","journal-title":"Arch Neurol"},{"key":"10960_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/103.2.315","author":"Y Robitaille","year":"1980","unstructured":"Robitaille Y, Carpenter S, Karpati G, DiMauro SD (1980) A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora\u2019s disease and normal ageing. Brain. https:\/\/doi.org\/10.1093\/brain\/103.2.315","journal-title":"Brain"},{"key":"10960_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.11.006","author":"A Sagnelli","year":"2014","unstructured":"Sagnelli A et al (2014) Adult polyglucosan body disease in a patient originally diagnosed with Fabry\u2019s disease. Neuromuscul Disord. https:\/\/doi.org\/10.1016\/j.nmd.2013.11.006","journal-title":"Neuromuscul Disord"},{"key":"10960_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31821cc65d","author":"K Segers","year":"2012","unstructured":"Segers K, Kadhim H, Colson C, Duttmann R, Glibert G (2012) Adult polyglucosan body disease masquerading as \u2018ALS with dementia of the Alzheimer type\u2019: an exceptional phenotype in a rare pathology. Alzheimer Dis Assoc Disord. https:\/\/doi.org\/10.1097\/WAD.0b013e31821cc65d","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10960_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fneur.2019.00192","volume":"10","author":"J Caga","year":"2019","unstructured":"Caga J, Hsieh S, Lillo P, Dudley K, Mioshi E (2019) The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol 10:192. https:\/\/doi.org\/10.3389\/fneur.2019.00192","journal-title":"Front Neurol"},{"issue":"10","key":"10960_CR34","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/jnnp.2006.104216","volume":"78","author":"N Figved","year":"2007","unstructured":"Figved N, Myhr K, Larsen J, Aarsland D (2007) Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry 78(10):1097\u20131102. https:\/\/doi.org\/10.1136\/jnnp.2006.104216","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-10960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-10960-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-10960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:35:55Z","timestamp":1653017755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-10960-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10960"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-10960-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest in regard to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The patient described in our study gave written informed consent for publication of clinical, genetic, and imaging data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}